Cargando…

Cell and Tissue Reaction Engineering

The completion of the Human Genome Project and the rapid progress in cell bi- ogy and biochemical engineering, are major forces driving the steady increase of approved biotech products, especially biopharmaceuticals, in the market. Today mammalian cell products ("products from cells"), pri...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Eibl, Regine (Autor), Eibl, Dieter (Autor), Pörtner, Ralf (Autor), Catapano, Gerardo (Autor), Czermak, Peter (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2009.
Edición:1st ed. 2009.
Colección:Principles and Practice,
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-540-68182-3
003 DE-He213
005 20230810203027.0
007 cr nn 008mamaa
008 100301s2009 gw | s |||| 0|eng d
020 |a 9783540681823  |9 978-3-540-68182-3 
024 7 |a 10.1007/978-3-540-68182-3  |2 doi 
050 4 |a QH585-585.5 
072 7 |a PSF  |2 bicssc 
072 7 |a PDN  |2 bicssc 
072 7 |a SCI017000  |2 bisacsh 
072 7 |a PSF  |2 thema 
072 7 |a PDN  |2 thema 
082 0 4 |a 571.6028  |2 23 
100 1 |a Eibl, Regine.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Cell and Tissue Reaction Engineering  |h [electronic resource] /  |c by Regine Eibl, Dieter Eibl, Ralf Pörtner, Gerardo Catapano, Peter Czermak. 
250 |a 1st ed. 2009. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2009. 
300 |a XI, 363 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Principles and Practice,  |x 1866-9158 
505 0 |a Mammalian Cells -- Mammalian Cell Culture Technology: An Emerging Field -- Characteristics of Mammalian Cells and Requirements for Cultivation -- Bioreactors for Mammalian Cells: General Overview -- Special Engineering Aspects -- Bioreactor Design and Scale-Up -- Special Applications -- Insect Cell-Based Recombinant Protein Production -- Bioreactors for Bioartificial Organs -- Plant Cell-Based Bioprocessing. 
520 |a The completion of the Human Genome Project and the rapid progress in cell bi- ogy and biochemical engineering, are major forces driving the steady increase of approved biotech products, especially biopharmaceuticals, in the market. Today mammalian cell products ("products from cells"), primarily monoclonals, cytokines, recombinant glycoproteins, and, increasingly, vaccines, dominate the biopharmaceutical industry. Moreover, a small number of products consisting of in vitro cultivated cells ("cells as product") for regenerative medicine have also been introduced in the market. Their efficient production requires comprehensive knowledge of biological as well as biochemical mammalian cell culture fundamentals (e.g., cell characteristics and metabolism, cell line establishment, culture medium optimization) and related engineering principles (e.g., bioreactor design, process scale-up and optimization). In addition, new developments focusing on cell line development, animal-free c- ture media, disposables and the implications of changing processes (multi-purpo- facilities) have to be taken into account. While a number of excellent books treating the basic methods and applications of mammalian cell culture technology have been published, only little attention has been afforded to their engineering aspects. The aim of this book is to make a contribution to closing this gap; it particularly focuses on the interactions between biological and biochemical and engineering principles in processes derived from cell cultures. It is not intended to give a c- prehensive overview of the literature. This has been done extensively elsewhere. 
650 0 |a Cytology  |x Technique. 
650 0 |a Biotechnology. 
650 0 |a Biomedical engineering. 
650 0 |a Pharmaceutical chemistry. 
650 0 |a Cytology. 
650 1 4 |a Cytological Techniques. 
650 2 4 |a Chemical Bioengineering. 
650 2 4 |a Biomedical Engineering and Bioengineering. 
650 2 4 |a Pharmaceutics. 
650 2 4 |a Cell Biology. 
650 2 4 |a Biotechnology. 
700 1 |a Eibl, Dieter.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
700 1 |a Pörtner, Ralf.  |e author.  |0 (orcid)0000-0003-1163-9718  |1 https://orcid.org/0000-0003-1163-9718  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
700 1 |a Catapano, Gerardo.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
700 1 |a Czermak, Peter.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783540863885 
776 0 8 |i Printed edition:  |z 9783540681755 
776 0 8 |i Printed edition:  |z 9783642018749 
776 0 8 |i Printed edition:  |z 9783662564318 
830 0 |a Principles and Practice,  |x 1866-9158 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-540-68182-3  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)